Clinical evaluation of the safety and efficacy of lecanemab treatment in early AD patients in Southeast China (a multicenter cohort study)
This study will provide crucial data on the effectiveness and safety of commercially available lecanemab in amyloid-positive early AD patients in Southeast Chinese population. The findings will further testify the potential ability of blood biomarkers in the prediction of therapeutic effects.
Authors
- Guoping Peng
- Yan Sun
Institutions
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70857_101471
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00